- Advertise
- OLE Scientific Interchange Workshops
- About OncLive
- Editorial Board
- CureToday.com
- TargetedOnc.com
- CancerNetwork.com
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
Atrium Health Levine Cancer Institute | Strategic Alliance Partners
Latest from Atrium Health Levine Cancer Institute
Dr. Ghosh on the Potential Advantages of Frontline CAR T-Cell Therapy in DLBCL
April 05, 2021
Video
Nilanjan Ghosh, MD, PhD, discusses the potential advantages of moving CAR T-cell therapy into the frontline setting for patients with diffuse large B-cell lymphoma.
Coleman and Brown Review Advancing Applications for PARP Inhibition in Ovarian Cancer
March 25, 2021
Podcast
Dr. Coleman and Dr. Brown discuss how understandings of BRCA and patient eligibility for PARP inhibitors have evolved in ovarian cancer, the effects of frontline maintenance trials on treatment recommendations, the clinical significance of the findings from the ARIEL4 trial, and where PARP inhibition is headed in the field.
Dr. Longshore on Comprehensive Vs Single-Gene Molecular Testing in Lung Cancer
March 22, 2021
Video
John Longshore, PhD, FACMG, discusses selecting between comprehensive vs single-gene molecular testing in lung cancer.
Dr. Longshore on Key Molecular Markers in Metastatic Lung Cancer
March 10, 2021
Video
John Longshore, PhD, FACMG, discusses key molecular markers in metastatic lung cancer.
Dr. Usmani on the Potential Utility of Allogeneic CAR T-Cell Therapy in Multiple Myeloma
March 09, 2021
Video
Saad Z. Usmani, MD, FACP, discusses the potential utility of allogeneic CAR T-cell therapy in multiple myeloma.